BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 14532772)

  • 21. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of marriage on bladder cancer mortality.
    Nelles JL; Joseph SA; Konety BR
    Urol Oncol; 2009; 27(3):263-7. PubMed ID: 18625568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marriage and mortality in bladder carcinoma.
    Gore JL; Kwan L; Saigal CS; Litwin MS
    Cancer; 2005 Sep; 104(6):1188-94. PubMed ID: 16078264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?
    Chamie K; Hu B; Devere White RW; Ellison LM
    BJU Int; 2008 Aug; 102(3):284-90. PubMed ID: 18410437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
    Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
    Coburn NG; Swallow CJ; Kiss A; Law C
    Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node evaluation in colorectal cancer patients: a population-based study.
    Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
    J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.
    Prout GR; Wesley MN; Yancik R; Ries LA; Havlik RJ; Edwards BK
    Cancer; 2005 Oct; 104(8):1638-47. PubMed ID: 16130136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
    Herr HW; Bochner BH; Dalbagni G; Donat SM; Reuter VE; Bajorin DF
    J Urol; 2002 Mar; 167(3):1295-8. PubMed ID: 11832716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of axillary lymphadenectomy on breast carcinoma survival.
    Joslyn SA; Konety BR
    Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.
    Hellenthal NJ; Ramírez ML; Evans CP; deVere White RW; Koppie TM
    J Urol; 2009 Jun; 181(6):2490-5. PubMed ID: 19371902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
    Abdel-Latif M; Abol-Enein H; El-Baz M; Ghoneim MA
    J Urol; 2004 Jul; 172(1):85-9. PubMed ID: 15201743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of care for the treatment of bladder cancer.
    Snyder C; Harlan L; Knopf K; Potosky A; Kaplan R
    J Urol; 2003 May; 169(5):1697-701. PubMed ID: 12686811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.